215 related articles for article (PubMed ID: 31149151)
1. DYNAMIC CHANGES OF TRAb AND TPOAb AFTER RADIOIODINE THERAPY IN GRAVES' DISEASE.
Dong Q; Liu X; Wang F; Xu Y; Liang C; Du W; Gao G
Acta Endocrinol (Buchar); 2017; 13(1):72-76. PubMed ID: 31149151
[TBL] [Abstract][Full Text] [Related]
2. Influence of high tissue-absorbed dose on anti-thyroid antibodies in radioiodine therapy of Graves' disease patients.
Listewnik MH; Piwowarska-Bilska H; Jasiakiewicz K; Birkenfeld B
Adv Clin Exp Med; 2021 Sep; 30(9):913-921. PubMed ID: 34418335
[TBL] [Abstract][Full Text] [Related]
3. The effect of radioiodine treatment on the characteristics of TRAb in Graves' disease.
Fang Y; Du WH; Zhang CX; Zhao SX; Song HD; Gao GQ; Dong M
BMC Endocr Disord; 2021 Nov; 21(1):238. PubMed ID: 34847904
[TBL] [Abstract][Full Text] [Related]
4. Correlation between serum beta-human chorionic gonadotropin levels and thyroid metabolic function in pregnant women with hyperemesis gravidarum.
Zheng H; Wang Q; Chen F
Chin J Physiol; 2023; 66(5):359-364. PubMed ID: 37929347
[TBL] [Abstract][Full Text] [Related]
5. TRAb elevations occurred even in the third trimester; a case of a mother of a child with neonatal thyroid dysfunction, who received radioactive iodine therapy for Graves' disease.
Suzuki N; Yoshihara A; Yoshimura Noh J; Kinoshita K; Ohnishi J; Saito M; Sugino K; Ito K
Endocr J; 2020 Oct; 67(10):1019-1022. PubMed ID: 32522908
[TBL] [Abstract][Full Text] [Related]
6. Correlation between thyroid volume and humoral thyroid autoimmunity after radioiodine therapy in Graves' disease.
Sawicka N; Sowiński J
Endokrynol Pol; 2012; 63(1):10-3. PubMed ID: 22378091
[TBL] [Abstract][Full Text] [Related]
7. The association of TSH-receptor antibody with the clinical and laboratory parameters in patients with newly diagnosed Graves' hyperthyroidism: experience from a tertiary referral center including a large number of patients with TSH-receptor antibody-negative patients with Graves' hyperthyroidism.
Zuhur SS; Bilen O; Aggul H; Topcu B; Celikkol A; Elbuken G
Endokrynol Pol; 2021; 72(1):14-21. PubMed ID: 32944926
[TBL] [Abstract][Full Text] [Related]
8. A pilot study on the beneficial effects of additional selenium supplementation to methimazole for treating patients with Graves’ disease.
Xu B; Wu D; Ying H; Zhang Y
Turk J Med Sci; 2019 Jun; 49(3):715-722. PubMed ID: 31023005
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of TSH receptor antibody by 'natural in vivo human assay' in neonates born to mothers with Graves' disease.
Tamaki H; Amino N; Iwatani Y; Tachi J; Kimura M; Mitsuda N; Ichihara K; Tanizawa O; Miyai K
Clin Endocrinol (Oxf); 1989 May; 30(5):493-503. PubMed ID: 2575017
[TBL] [Abstract][Full Text] [Related]
10. Effects of glucocorticoid pulse therapy on thyroid function and thyroid antibodies in children with graves' disease.
Hu Y; Man Y; Sun X; Xue Y
Ital J Pediatr; 2021 Mar; 47(1):46. PubMed ID: 33653401
[TBL] [Abstract][Full Text] [Related]
11. Graves Disease Induced by Radioiodine Therapy for Toxic Nodular Goiter: A Case Report.
Yürekli Y; Cengiz A; Güney E
Mol Imaging Radionucl Ther; 2015 Oct; 24(3):135-7. PubMed ID: 27529890
[TBL] [Abstract][Full Text] [Related]
12. Radioiodine thyroid ablation in graves' hyperthyroidism: merits and pitfalls.
Nwatsock JF; Taieb D; Tessonnier L; Mancini J; Dong-A-Zok F; Mundler O
World J Nucl Med; 2012 Jan; 11(1):7-11. PubMed ID: 22942775
[TBL] [Abstract][Full Text] [Related]
13. fT3:fT4 ratio in Graves' disease - correlation with TRAb level, goiter size and age of onset.
Minasyan M; Dulęba A; Smalarz A; Stręk M; Bryniarski P; Przybylik-Mazurek E; Hubalewska-Dydejczyk A
Folia Med Cracov; 2020 Sep; 60(2):15-27. PubMed ID: 33252592
[TBL] [Abstract][Full Text] [Related]
14. Differentiation of postpartum Graves' thyrotoxicosis from postpartum destructive thyrotoxicosis using antithyrotropin receptor antibodies and thyroid blood flow.
Ide A; Amino N; Kang S; Yoshioka W; Kudo T; Nishihara E; Ito M; Nakamura H; Miyauchi A
Thyroid; 2014 Jun; 24(6):1027-31. PubMed ID: 24400892
[TBL] [Abstract][Full Text] [Related]
15. Low Vitamin D Status is Associated with Increased Thyrotropin-Receptor Antibody Titer in Graves Disease.
Zhang H; Liang L; Xie Z
Endocr Pract; 2015 Mar; 21(3):258-63. PubMed ID: 25370319
[TBL] [Abstract][Full Text] [Related]
16. Hashimoto's thyroiditis: TGAb, TPOAb, TRAb and recovery from hypothyroidism.
Takasu N; Yoshimura Noh J
Expert Rev Clin Immunol; 2008 Mar; 4(2):221-37. PubMed ID: 20477052
[TBL] [Abstract][Full Text] [Related]
17. The association between serum adenosine deaminase levels and Graves' disease.
Lu CF; Liu WS; Ge XQ; Xu F; Su JB; Wang XQ; Wang Y
Endocr Connect; 2021 Sep; 10(10):1227-1233. PubMed ID: 34473081
[TBL] [Abstract][Full Text] [Related]
18. Changes in Thyroid Peroxidase and Thyroglobulin Antibodies Might Be Associated with Graves' Disease Relapse after Antithyroid Drug Therapy.
Choi YM; Kwak MK; Hong SM; Hong EG
Endocrinol Metab (Seoul); 2019 Sep; 34(3):268-274. PubMed ID: 31565879
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal Characterization of Autoantibodies to the Thyrotropin Receptor (TRAb) During Alemtuzumab Therapy: Evidence that TRAb May Precede Thyroid Dysfunction by Many Years.
Muller I; Willis M; Healy S; Nasser T; Loveless S; Butterworth S; Zhang L; Draman MS; Taylor PN; Robertson N; Dayan CM; Ludgate ME
Thyroid; 2018 Dec; 28(12):1682-1693. PubMed ID: 30351224
[TBL] [Abstract][Full Text] [Related]
20. Decreased serum level of IL-7 in patients with active Graves' disease.
Motylewska E; Nieć M; Siejka A; Komorowski J; Ławnicka H; Świętosławski J; Stępień H
Cytokine; 2015 Oct; 75(2):373-9. PubMed ID: 26113403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]